M
Miia Kivipelto
Researcher at Karolinska University Hospital
Publications - 516
Citations - 70761
Miia Kivipelto is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 91, co-authored 447 publications receiving 58328 citations. Previous affiliations of Miia Kivipelto include National Institute for Health and Welfare & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Dementia after age 75: survival in different severity stages and years of life lost.
TL;DR: A similar impact of dementia and CVD on survival is found, but following diagnosis, persons with dementia, and especially women, spent half of their remaining lives in the severe disabling stages of the disease.
Journal ArticleDOI
The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
Craig W. Ritchie,Graciela Muniz-Terrera,Miia Kivipelto,Alina Solomon,Brian D. M. Tom,José Luis Molinuevo +5 more
TL;DR: The EPAD LCS is achieving its primary objective of trial readiness and the structured approach to data release as manifest by this first data release of V500.0 will assist researchers to describe and compare their findings as well as in systematic reviews and meta-analyses.
Journal ArticleDOI
Cholesterol-modifying strategies for Alzheimer’s disease
Alina Solomon,Miia Kivipelto +1 more
TL;DR: Integrative interventions focusing on overall risk instead of individual risk factors may bring more benefit to individuals at risk of Alzheimer’s disease, and cholesterol-modifying strategies may be more effective in dementia/AD prevention.
Journal ArticleDOI
Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health.
Valerio Leoni,Alina Solomon,Anita Lövgren-Sandblom,Lennart Minthon,Kaj Blennow,Oskar Hansson,Lars-Olof Wahlund,Miia Kivipelto,Ingemar Björkhem +8 more
TL;DR: The data suggest that 24OHC may be more sensitive than the classical biomarkers in an early phase of the neurodegenerative process and a better marker for "brain health" in old age.
Journal ArticleDOI
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies
Giovanni B. Frisoni,Giovanni B. Frisoni,José Luis Molinuevo,Daniele Altomare,Daniele Altomare,Emmanuel Carrera,Frederik Barkhof,Johannes Berkhof,Julien Delrieu,Bruno Dubois,Miia Kivipelto,Agneta Nordberg,Agneta Nordberg,Jonathan M. Schott,Wiesje M. van der Flier,Bruno Vellas,Frank Jessen,Frank Jessen,Philip Scheltens,Craig W. Ritchie +19 more
TL;DR: Dementia clinics will need structural and functional changes to adapt to novel technologies and increased patients’ demands, and brand‐new services may need to be developed with specific skills on risk profiling, risk communication, and personalized risk reduction plans.